Annual CFF
$13.62 M
-$25.96 M-65.59%
31 December 2023
Summary:
Orgenesis annual cash flow from financing activities is currently $13.62 million, with the most recent change of -$25.96 million (-65.59%) on 31 December 2023. During the last 3 years, it has risen by +$7.74 million (+131.56%). ORGS annual CFF is now -65.59% below its all-time high of $39.58 million, reached on 31 December 2022.ORGS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$4.43 M
-$2.08 M-31.88%
30 September 2024
Summary:
Orgenesis quarterly cash flow from financing activities is currently $4.43 million, with the most recent change of -$2.08 million (-31.88%) on 30 September 2024. Over the past year, it has increased by +$2.84 million (+177.71%). ORGS quarterly CFF is now -77.24% below its all-time high of $19.48 million, reached on 31 December 2022.ORGS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$15.79 M
+$2.84 M+21.92%
30 September 2024
Summary:
Orgenesis TTM cash flow from financing activities is currently $15.79 million, with the most recent change of +$2.84 million (+21.92%) on 30 September 2024. Over the past year, it has dropped by -$16.09 million (-50.48%). ORGS TTM CFF is now -65.30% below its all-time high of $45.49 million, reached on 31 March 2023.ORGS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.6% | +177.7% | -50.5% |
| 3 y3 years | +131.6% | +10000.0% | +2092.4% |
| 5 y5 years | -61.2% | +3990.3% | -13.4% |
ORGS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.6% | >+9999.0% | -77.2% | +505.0% | -65.3% | +888.1% |
| 5 y | 5 years | -65.6% | >+9999.0% | -77.2% | +505.0% | -65.3% | +888.1% |
| alltime | all time | -65.6% | >+9999.0% | -77.2% | +394.1% | -65.3% | +888.1% |
Orgenesis Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.43 M(-31.9%) | $15.79 M(+21.9%) |
| June 2024 | - | $6.51 M(+80.2%) | $12.95 M(+14.4%) |
| Mar 2024 | - | $3.61 M(+195.0%) | $11.32 M(-16.9%) |
| Dec 2023 | $13.62 M(-65.6%) | $1.23 M(-23.3%) | $13.62 M(-57.3%) |
| Sept 2023 | - | $1.60 M(-67.3%) | $31.88 M(-19.2%) |
| June 2023 | - | $4.89 M(-17.3%) | $39.47 M(-13.2%) |
| Mar 2023 | - | $5.91 M(-69.7%) | $45.49 M(+14.9%) |
| Dec 2022 | $39.58 M(<-9900.0%) | $19.48 M(+112.0%) | $39.58 M(+108.3%) |
| Sept 2022 | - | $9.19 M(-15.7%) | $19.00 M(+93.7%) |
| June 2022 | - | $10.90 M(>+9900.0%) | $9.81 M(-589.6%) |
| Mar 2022 | - | $1000.00(-100.1%) | -$2.00 M(+1789.6%) |
| Dec 2021 | -$106.00 K(-101.8%) | -$1.09 M(>+9900.0%) | -$106.00 K(-114.7%) |
| Sept 2021 | - | -$4000.00(-99.6%) | $720.00 K(+0.7%) |
| June 2021 | - | -$905.00 K(-147.7%) | $715.00 K(-49.7%) |
| Mar 2021 | - | $1.90 M(-805.6%) | $1.42 M(-75.8%) |
| Dec 2020 | $5.88 M(-75.6%) | -$269.00 K(+2888.9%) | $5.88 M(-64.5%) |
| Sept 2020 | - | -$9000.00(-95.5%) | $16.57 M(+0.6%) |
| June 2020 | - | -$198.00 K(-103.1%) | $16.46 M(-31.0%) |
| Mar 2020 | - | $6.36 M(-39.0%) | $23.85 M(-1.0%) |
| Dec 2019 | $24.10 M(-31.3%) | $10.42 M(-9236.8%) | $24.10 M(+32.2%) |
| Sept 2019 | - | -$114.00 K(-101.6%) | $18.23 M(-51.7%) |
| June 2019 | - | $7.19 M(+9.0%) | $37.75 M(-1.0%) |
| Mar 2019 | - | $6.60 M(+45.1%) | $38.12 M(+8.7%) |
| Nov 2018 | $35.06 M(+319.1%) | $4.55 M(-76.6%) | $35.06 M(+1.5%) |
| Aug 2018 | - | $19.41 M(+156.6%) | $34.53 M(+101.7%) |
| May 2018 | - | $7.56 M(+113.6%) | $17.11 M(+93.0%) |
| Feb 2018 | - | $3.54 M(-11.8%) | $8.87 M(+6.0%) |
| Nov 2017 | $8.37 M(+294.0%) | $4.01 M(+101.2%) | $8.37 M(+35.9%) |
| Aug 2017 | - | $2.00 M(-392.7%) | $6.16 M(+15.5%) |
| May 2017 | - | -$682.00 K(-122.5%) | $5.33 M(-20.1%) |
| Feb 2017 | - | $3.04 M(+68.1%) | $6.67 M(+214.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2016 | $2.12 M(-68.2%) | $1.81 M(+54.4%) | $2.12 M(-62.2%) |
| Aug 2016 | - | $1.17 M(+78.6%) | $5.62 M(+0.8%) |
| May 2016 | - | $655.00 K(-143.4%) | $5.58 M(+7.8%) |
| Feb 2016 | - | -$1.51 M(-128.4%) | $5.17 M(-22.4%) |
| Nov 2015 | $6.67 M(+143.6%) | $5.30 M(+370.0%) | $6.67 M(+340.1%) |
| Aug 2015 | - | $1.13 M(+351.2%) | $1.51 M(-27.4%) |
| May 2015 | - | $250.00 K(-1885.7%) | $2.09 M(+2.5%) |
| Feb 2015 | - | -$14.00 K(-109.3%) | $2.04 M(-25.6%) |
| Nov 2014 | $2.74 M(+33.5%) | $150.50 K(-91.1%) | $2.74 M(+5.8%) |
| Aug 2014 | - | $1.70 M(+749.5%) | $2.59 M(+191.4%) |
| May 2014 | - | $200.00 K(-70.9%) | $887.60 K(-60.3%) |
| Feb 2014 | - | $687.60 K(>+9900.0%) | $2.24 M(+9.2%) |
| Nov 2013 | $2.05 M(+91.3%) | $0.00(0.0%) | $2.05 M(0.0%) |
| Aug 2013 | - | $0.00(-100.0%) | $2.05 M(-19.6%) |
| May 2013 | - | $1.55 M(+210.0%) | $2.55 M(+131.8%) |
| Feb 2013 | - | $500.00 K(>+9900.0%) | $1.10 M(+2.6%) |
| Nov 2012 | $1.07 M(>+9900.0%) | $0.00(-100.0%) | $1.07 M(0.0%) |
| Aug 2012 | - | $500.00 K(+400.0%) | $1.07 M(+87.5%) |
| May 2012 | - | $100.00 K(-78.8%) | $571.70 K(+21.2%) |
| Feb 2012 | - | $471.70 K(>+9900.0%) | $471.70 K(>+9900.0%) |
| Nov 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Aug 2010 | - | $0.00(0.0%) | $55.00 K(0.0%) |
| May 2010 | - | $0.00(-100.0%) | $55.00 K(0.0%) |
| Nov 2009 | $55.00 K(0.0%) | $55.00 K(>+9900.0%) | $55.00 K(>+9900.0%) |
| Aug 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00 | $0.00 |
| Nov 2008 | $55.00 K | - | - |
FAQ
- What is Orgenesis annual cash flow from financing activities?
- What is the all time high annual CFF for Orgenesis?
- What is Orgenesis annual CFF year-on-year change?
- What is Orgenesis quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Orgenesis?
- What is Orgenesis quarterly CFF year-on-year change?
- What is Orgenesis TTM cash flow from financing activities?
- What is the all time high TTM CFF for Orgenesis?
- What is Orgenesis TTM CFF year-on-year change?
What is Orgenesis annual cash flow from financing activities?
The current annual CFF of ORGS is $13.62 M
What is the all time high annual CFF for Orgenesis?
Orgenesis all-time high annual cash flow from financing activities is $39.58 M
What is Orgenesis annual CFF year-on-year change?
Over the past year, ORGS annual cash flow from financing activities has changed by -$25.96 M (-65.59%)
What is Orgenesis quarterly cash flow from financing activities?
The current quarterly CFF of ORGS is $4.43 M
What is the all time high quarterly CFF for Orgenesis?
Orgenesis all-time high quarterly cash flow from financing activities is $19.48 M
What is Orgenesis quarterly CFF year-on-year change?
Over the past year, ORGS quarterly cash flow from financing activities has changed by +$2.84 M (+177.71%)
What is Orgenesis TTM cash flow from financing activities?
The current TTM CFF of ORGS is $15.79 M
What is the all time high TTM CFF for Orgenesis?
Orgenesis all-time high TTM cash flow from financing activities is $45.49 M
What is Orgenesis TTM CFF year-on-year change?
Over the past year, ORGS TTM cash flow from financing activities has changed by -$16.09 M (-50.48%)